KONDENSIERTE IMIDAZOLDERIVATE ALS MODULATOREN VIELFACHER MEDIKAMENTENRESISTENZ
This invention concerns the compounds of formulathe N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein the dotted line is an optional bond; n is 1 or 2; R1 is hydrogen; halo; formyl; C1-4alkyl optionally substituted with hydroxy, C1...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | German |
Published |
24.09.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This invention concerns the compounds of formulathe N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein the dotted line is an optional bond; n is 1 or 2; R1 is hydrogen; halo; formyl; C1-4alkyl optionally substituted with hydroxy, C1-4alkyloxy, C1-4alkylcarbonyloxy, imidazolyl, thiazolyl or oxazolyl; or a radical of formula -X-COOR5, -X-CONR6R7 or -X-COR10 wherein -X- is a direct bond, C1-4alkanediyl or C2-6alkenediyl; R5 is hydrogen, C1-12alkyl, Ar, Het, C1-6alkyl substituted with C1-4alkyloxy, aryl or heteroaryl; R6 and R7 each independently are hydrogen or C1-4alkyl; R2 is hydrogen, halo, C1-4alkyl, hydroxyC1-4alkyl, C1-4alkyloxycarbonyl, carboxyl, formyl or phenyl; R3 is hydrogen, C1-4alkyl or C1-4alkyloxy; R4 is hydrogen, halo, C1-4alkyl, C1-4alkyloxy or haloC1-4alkyl; Z is -CH2-, -CH2-CH2-, -CH=CH-, -CHOH-CH2-, -O-CH2-, -C(=O)-CH2- or -C(=NOH)-CH2-; -A-B- is a bivalent radical; A1 is a direct bond, optionally substituted C1-6alkanediyl, C1-6alkanediyl-oxy-C1-6alkanediyl, carbonyl, C1-6alkanediylcarbonyl, optionally substituted C1-6alkanediyloxy; A2 is a direct bond or C1-6alkanediyl; and Q is aryl. Processes for preparing said products, formulations comprising said products and their use as a medicine are disclosed, in particular for inhibiting or reversing the effects of multidrug resistance. |
---|---|
AbstractList | This invention concerns the compounds of formulathe N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein the dotted line is an optional bond; n is 1 or 2; R1 is hydrogen; halo; formyl; C1-4alkyl optionally substituted with hydroxy, C1-4alkyloxy, C1-4alkylcarbonyloxy, imidazolyl, thiazolyl or oxazolyl; or a radical of formula -X-COOR5, -X-CONR6R7 or -X-COR10 wherein -X- is a direct bond, C1-4alkanediyl or C2-6alkenediyl; R5 is hydrogen, C1-12alkyl, Ar, Het, C1-6alkyl substituted with C1-4alkyloxy, aryl or heteroaryl; R6 and R7 each independently are hydrogen or C1-4alkyl; R2 is hydrogen, halo, C1-4alkyl, hydroxyC1-4alkyl, C1-4alkyloxycarbonyl, carboxyl, formyl or phenyl; R3 is hydrogen, C1-4alkyl or C1-4alkyloxy; R4 is hydrogen, halo, C1-4alkyl, C1-4alkyloxy or haloC1-4alkyl; Z is -CH2-, -CH2-CH2-, -CH=CH-, -CHOH-CH2-, -O-CH2-, -C(=O)-CH2- or -C(=NOH)-CH2-; -A-B- is a bivalent radical; A1 is a direct bond, optionally substituted C1-6alkanediyl, C1-6alkanediyl-oxy-C1-6alkanediyl, carbonyl, C1-6alkanediylcarbonyl, optionally substituted C1-6alkanediyloxy; A2 is a direct bond or C1-6alkanediyl; and Q is aryl. Processes for preparing said products, formulations comprising said products and their use as a medicine are disclosed, in particular for inhibiting or reversing the effects of multidrug resistance. |
Author | SURLERAUX, LOUIS LEENAERTS, ELISABETH SOMMEN, MARIA JANSSENS, EDUARD |
Author_xml | – fullname: SURLERAUX, LOUIS – fullname: SOMMEN, MARIA – fullname: LEENAERTS, ELISABETH – fullname: JANSSENS, EDUARD |
BookMark | eNqNyrsKwjAYhuEMOni6h-DukoLaMTRf6U9zgCR26FKKxEnSQr1_7OAFOD3w8u7ZJk857ZhtnVWwgeAjOBlSsndawVMn1yB14Maph5bReVjeEXQtqwaeGyhqpYGNsB6Bwmp_ZNvX-F7S6eeBnWvEqrmkeRrSMo_PlNNnULiWNyGKexmjKP6avgzLMec |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | DE69722389TT2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_DE69722389TT23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:11:24 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_DE69722389TT23 |
Notes | Application Number: DE19976022389T |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090924&DB=EPODOC&CC=DE&NR=69722389T2 |
ParticipantIDs | epo_espacenet_DE69722389TT2 |
PublicationCentury | 2000 |
PublicationDate | 20090924 |
PublicationDateYYYYMMDD | 2009-09-24 |
PublicationDate_xml | – month: 09 year: 2009 text: 20090924 day: 24 |
PublicationDecade | 2000 |
PublicationYear | 2009 |
RelatedCompanies | JANSSEN PHARMACEUTICA N.V |
RelatedCompanies_xml | – name: JANSSEN PHARMACEUTICA N.V |
Score | 2.7387218 |
Snippet | This invention concerns the compounds of formulathe N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | KONDENSIERTE IMIDAZOLDERIVATE ALS MODULATOREN VIELFACHER MEDIKAMENTENRESISTENZ |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090924&DB=EPODOC&locale=&CC=DE&NR=69722389T2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8haNSbokZFzWLMbosIG2OHxYy1yyajIzAI4ULoWhI9AJEZ_31fx4eeOLVpk5f2Je_j19f-CvDctBE0SCEN0TIRoPDXhsFFXRq1Frcyx8pEtrltwZrh0HwfW-MSfO7ewhQ8oT8FOSJaVIb2nhf-evV3iEWKu5XrF_6BQ8u3IHWJvkPHTg3xhE7aLu0lJPF133cJ1VnfbTo2BsKWk6K7PlJptOLZp6O2epWy-h9SgnM47qG0RX4BJSErcOrvfl6rwEl3W_DG7tb21pfAOgkjlA0iiimohj6HeJMkJgjERh4OePFA6yZkGHtp0qdMG0U0Djw_pH1NUTh2PMXaTxkqPBpgO7mCp4CmfmjgwqZ7LUwJ3e8hrTeuobxYLuQNaGJmW8LiPJuZAvXOHW4qTFh3zLkt57x2C9UDgu4OzlbhbFM9UVWYeyjnX9_yAYNwzh8L7f0CwbSF_A |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8haMSbokbFj8WY3RYRNsYOixlrl01GR2AshAuh60j0AERm_Pd9HR964tSmTV7al7yPX1_7K8Bzy0TQkIlME20dAQp_bWpcNDKt3uZGahmpSDe3LVjLH-nvY2Ncgs_dW5iCJ_SnIEdEi0rR3vPCX6_-DrFIcbdy_cI_cGj55sU2UXfo2KojnlBJx6b9iESu6ro2oSob2C3LxEDYtmJ010emZOeVqVPSka9SVv9DincGx32UtsjPoSSyKlTc3c9rVTjpbQve2N3a3voCWDdihLJhQDEFVdDnEGcShQSBWOLggBMOlV5ERqETRwPKlCSgoee4Ph0oksKx60jWfspQ4cEQ28klPHk0dn0NFzbda2FK6H4PcaN5BeXFcpFdgyJmpiEMztOZLlDv3OK6xIQNS5-b2ZzXb6B2QNDtwdlHqPhxL5yGAevW4HRTSZEVmTso51_f2T0G5Jw_FJr8BS5EiOk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=KONDENSIERTE+IMIDAZOLDERIVATE+ALS+MODULATOREN+VIELFACHER+MEDIKAMENTENRESISTENZ&rft.inventor=SURLERAUX%2C+LOUIS&rft.inventor=SOMMEN%2C+MARIA&rft.inventor=LEENAERTS%2C+ELISABETH&rft.inventor=JANSSENS%2C+EDUARD&rft.date=2009-09-24&rft.externalDBID=T2&rft.externalDocID=DE69722389TT2 |